4.7 Review

Next-Generation Probiotics for Inflammatory Bowel Disease

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Nutrition & Dietetics

Effect of Probiotics on Respiratory Tract Allergic Disease and Gut Microbiota

Jinli Huang et al.

Summary: This review provides an overview of the clinical features of allergic rhinitis (AR) and allergic asthma (AA), as well as the potential role of probiotics in the prevention and treatment of these diseases. The study found that an imbalance in gut microbiota may contribute to the development of allergic diseases, and probiotics can modulate immune responses to improve inflammation and enhance host defense.

FRONTIERS IN NUTRITION (2022)

Review Food Science & Technology

Nutraceuticals and Diet Supplements in Crohn's Disease: A General Overview of the Most Promising Approaches in the Clinic

Barbara De Conno et al.

Summary: Crohn's disease is a chronic inflammatory gastrointestinal disorder. Nutraceuticals may provide a more natural approach to control the disease, as they have anti-inflammatory, analgesic, and immunoregulatory properties. However, there is limited research and lack of education among healthcare professionals on their clinical effectiveness. These supplements can be used as adjunctive therapies or for symptomatic relief in CD patients.
Article Chemistry, Multidisciplinary

Optotheranostic Nanosystem with Phone Visual Diagnosis and Optogenetic Microbial Therapy for Ulcerative Colitis At-Home Care

Meihui Cui et al.

Summary: A study developed an optotheranostic nanosystem for self-diagnosis and long-acting mitigation of ulcerative colitis (UC). The system utilized smartphone optical sensing for disease prescreening and an optogenetic engineered bacteria system for real-time intervention. Treatment with IL-10-secreting EcN effectively suppressed intestinal inflammatory response and protected intestinal mucosa in UC mice.

ACS NANO (2021)

Article Biochemistry & Molecular Biology

Engineered Lactobacillus paracasei Producing Palmitoylethanolamide (PEA) Prevents Colitis in Mice

Giuseppe Esposito et al.

Summary: This study demonstrates that utilizing NAPE-PLD-expressing Lactobacillus paracasei F19 (pNAPE-LP) and ultra-low palmitate supply can enhance the delivery of PEA in the intestine, leading to significant improvements in clinical and histological damage scores in a murine model of ulcerative colitis. The coadministration of pNAPE-LP and palmitate results in reduced neutrophil infiltration, decreased levels of pro-inflammatory cytokines and oxidative stress markers, and improved epithelial barrier integrity, suggesting a potential new therapeutic approach for controlling intestinal inflammation.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Pharmacology & Pharmacy

A Palmitoylethanolamide Producing Lactobacillus paracasei Improves Clostridium difficile Toxin A-Induced Colitis

Giuseppe Esposito et al.

Summary: The newly designed PEA-producing probiotic showed therapeutic potential in inhibiting colonic inflammation and restoring tight junction protein expression in a mouse model of CDI.

FRONTIERS IN PHARMACOLOGY (2021)

Article Microbiology

Akkermansia muciniphila secretes a glucagon-like peptide-1-inducing protein that improves glucose homeostasis and ameliorates metabolic disease in mice

Hyo Shin Yoon et al.

Summary: The study demonstrates that Akkermansia muciniphila increases thermogenesis and GLP-1 secretion in mice by inducing uncoupling protein 1. A protein secreted by A. muciniphila, P9, interacts with ICAM-2 and can target metabolic diseases. This interaction could be a potential therapeutic target for such diseases.

NATURE MICROBIOLOGY (2021)

Review Microbiology

Recognizing the Benefits of Pre-/Probiotics in Metabolic Syndrome and Type 2 Diabetes Mellitus Considering the Influence of Akkermansia muciniphila as a Key Gut Bacterium

Raluca Anca Corb Aron et al.

Summary: This review emphasizes the influence of gut microbiota on metabolic syndrome and type 2 diabetes mellitus, especially the positive effects of Akkermansia muciniphila supplementation on MetS, as well as the interaction between dietary polyphenols and gut microbiota.

MICROORGANISMS (2021)

Article Biotechnology & Applied Microbiology

An engineered probiotic secreting Sj16 ameliorates colitis via Ruminococcaceae/butyrate/retinoic acid axis

Lifu Wang et al.

Summary: Most IBD patients struggle to maintain long-term remission, necessitating the development of new therapeutic strategies. This study utilized genetically engineered E. coli Nissle 1917 to express Sj16 in the gastrointestinal tract, successfully attenuating colitis symptoms in mice by promoting intestinal microbiota diversity and enhancing butyrate production, which in turn modulated immune responses. The findings suggest EcN-Sj16 as a promising engineered probiotic for IBD treatment.

BIOENGINEERING & TRANSLATIONAL MEDICINE (2021)

Article Immunology

Construction of a sustainable 3-hydroxybutyrate-producing probiotic Escherichia coli for treatment of colitis

Xu Yan et al.

Summary: Colitis is a difficult-to-treat disease of the colon. Probiotic bacteria, specifically engineered Escherichia coli Nissle 1917, have been used to produce the ketone body (R)-3-hydroxybutyrate (3HB) in the gut of mice with colitis, leading to improved gut health and potential treatment of the disease.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

Review Pharmacology & Pharmacy

Biomimetic Bacterial Membrane Vesicles for Drug Delivery Applications

Sajid Fazal et al.

Summary: Developing a nanodrug delivery system that meets various criteria is challenging. Exosomes from mammalian cells are biocompatible but expensive, while Bacterial Membrane Vesicles (BMVs) show potential as cost-effective alternatives for large-scale production with further exploration needed as drug delivery systems.

PHARMACEUTICS (2021)

Review Medicine, General & Internal

Highlighting the Relevance of Gut Microbiota Manipulation in Inflammatory Bowel Disease

Flavia Maria Pavel et al.

Summary: Inflammatory bowel disease (IBD) encompasses Crohn's disease (CD) and ulcerative colitis (UC), characterized by chronic gut inflammation due to genetic predisposition and environmental factors. Microbial studies have identified the role of gut microbiome in IBD pathophysiology, highlighting the importance of microbiome management in treatment, with probiotics and prebiotics showing beneficial effects.

DIAGNOSTICS (2021)

Review Biotechnology & Applied Microbiology

Engineered Probiotics for Detection and Treatment of Inflammatory Intestinal Diseases

Maria Barra et al.

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)

Article Biotechnology & Applied Microbiology

Alterations of Akkermansia muciniphila in the inflammatory bowel disease patients with washed microbiota transplantation

Ting Zhang et al.

APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2020)

Review Medicine, General & Internal

Probiotics for induction of remission in ulcerative colitis

Lakhbir Kaur et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2020)

Review Gastroenterology & Hepatology

The role of short-chain fatty acids in microbiota-gut-brain communication

Boushra Dalile et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)

Article Multidisciplinary Sciences

Bacterial outer membrane vesicles engineered with lipidated antigens as a platform for Staphylococcus aureus vaccine

Carmela Irene et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Review Cell Biology

Endocannabinoid-related compounds in gastrointestinal diseases

Marcella Pesce et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)

Article Immunology

Oral engineered Bifidobacterium longum expressing rhMnSOD to suppress experimental colitis

Mengge Liu et al.

INTERNATIONAL IMMUNOPHARMACOLOGY (2018)

Article Medicine, Research & Experimental

Oral Escherichia coli expressing IL-35 meliorates experimental colitis in mice

Baoren Zhang et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2018)

Article Multidisciplinary Sciences

An ingestible bacterial-electronic system to monitor gastrointestinal health

Mark Mimee et al.

SCIENCE (2018)

Article Pharmacology & Pharmacy

Endocannabinoids in the treatment of gasytrointestinal inflammation and symptoms

Marcella Pesce et al.

CURRENT OPINION IN PHARMACOLOGY (2018)

Article Biotechnology & Applied Microbiology

Engineered bacteria can function in the mammalian gut long-term as live diagnostics of inflammation

David T. Riglar et al.

NATURE BIOTECHNOLOGY (2017)

Article Microbiology

Outer Membrane Vesicles (OMVs) of Gram-negative Bacteria: A Perspective Update

Arif Tasleem Jan

FRONTIERS IN MICROBIOLOGY (2017)

Review Gastroenterology & Hepatology

Mend Your Fences The Epithelial Barrier and its Relationship With Mucosal Immunity in Inflammatory Bowel Disease

Eva Martini et al.

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2017)

Article Cell Biology

How informative is the mouse for human gut microbiota research?

Thi Loan Anh Nguyen et al.

DISEASE MODELS & MECHANISMS (2015)

Review Microbiology

Roles of bacterial membrane vesicles

Eric Daniel Avila-Calderon et al.

ARCHIVES OF MICROBIOLOGY (2015)

Review Immunology

The gut microbiota and inflammatory bowel disease

Katsuyoshi Matsuoka et al.

SEMINARS IN IMMUNOPATHOLOGY (2015)

Article Gastroenterology & Hepatology

Oral Delivery of IL-27 Recombinant Bacteria Attenuates Immune Colitis in Mice

Miranda L. Hanson et al.

GASTROENTEROLOGY (2014)

Review Gastroenterology & Hepatology

IBD-what role do Proteobacteria play?

Indrani Mukhopadhya et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2012)

Article Gastroenterology & Hepatology

Treatment of Colitis with a Commensal Gut Bacterium Engineered to Secrete Human TGF-β1 Under the Control of Dietary Xylan

Zaed Z. R. Hamady et al.

INFLAMMATORY BOWEL DISEASES (2011)

Article Gastroenterology & Hepatology

Disease Phenotype and Genotype Are Associated with Shifts in Intestinal-associated Microbiota in Inflammatory Bowel Diseases

Daniel N. Frank et al.

INFLAMMATORY BOWEL DISEASES (2011)

Article Biotechnology & Applied Microbiology

Evaluation of the Anti-Inflammatory Effect of Milk Fermented by a Strain of IL-10-Producing Lactococcus lactis Using a Murine Model of Crohn's Disease

Silvina del Carmen et al.

JOURNAL OF MOLECULAR MICROBIOLOGY AND BIOTECHNOLOGY (2011)

Review Nutrition & Dietetics

Modulation of natural immunity in the gut by Escherichia coli strain Nissle 1917

Ilja Trebichavsky et al.

NUTRITION REVIEWS (2010)

Article Multidisciplinary Sciences

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

Harry Sokol et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Biotechnology & Applied Microbiology

Lactococcus lactis, an efficient cell factory for recombinant protein production and secretion

E. Morello et al.

JOURNAL OF MOLECULAR MICROBIOLOGY AND BIOTECHNOLOGY (2008)

Article Multidisciplinary Sciences

The genome sequence of Bifidobacterium longum reflects its adaptation to the human gastrointestinal tract

MA Schell et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)

Article Multidisciplinary Sciences

Treatment of murine colitis by Lactococcus lactis secreting interleukin-10

L Steidler et al.

SCIENCE (2000)